NCIt definition : An orally available inhibitor of the specific KRAS mutation, p.G12C, with potential
antineoplastic activity. Upon oral administration, sotorasib selectively targets,
binds to and inhibits the activity of the KRAS p.G12C mutant. This may inhibit growth
in KRAS p.G12C-expressing tumor cells. The KRAS p.G12C mutation is seen in some tumor
cell types and plays a key role in tumor cell proliferation.;
UNII : 2B2VM6UC8G;
InChIKey : NXQKSXLFSAEQCZ-SFHVURJKSA-N;
CAS number : 2296729-00-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2296729-00-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;